{"id":8685,"date":"2010-06-28T10:17:23","date_gmt":"2010-06-28T14:17:23","guid":{"rendered":"http:\/\/asweetlife.org\/?p=8685"},"modified":"2015-12-29T09:01:19","modified_gmt":"2015-12-29T14:01:19","slug":"type-2-diabetics-may-be-able-to-tolerate-higher-doses-of-metformin-using-glumetza","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=8685","title":{"rendered":"Type 2 Diabetics May be Able to Tolerate Higher Doses of Metformin Using Glumetza"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo-1.png\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-8426 lazyload\" style=\"margin: 4px;\" title=\"depomed_logo\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo-1.png\" alt=\"\" width=\"177\" height=\"59\" \/><\/a>A <a href=\"http:\/\/ir.santarus.com\/releasedetail.cfm?ReleaseID=483008\" target=\"_blank\">press release<\/a> issued today by Depomed, Inc. and Santarus, Inc says that according to the clinical trial results, patients previously intolerant of metformin may be able to tolerate higher efficacious doses of metformin when treated with GLUMETZA, with fewer gastrointestinal side effects. GLUMETZA is a once-daily, extended release formulation of metformin, and is approved for use in adults with type 2 diabetes mellitus. Notably:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Patients treated with GLUMETZA versus other metformin products were able to use a higher mean maximum tolerated dose (1477 mg vs. 1204 mg, respectively).<\/li>\n<li>Overall, 95.4% of patients treated with GLUMETZA tolerated at least 1000 mg; 42.5% of patients tolerated up to 2000 mg of GLUMETZA.<\/li>\n<li>The incidence of GI adverse events, including abdominal pain, diarrhea, GI upset, and nausea, was lower with GLUMETZA than with previous metformin formulations (38% vs. 88%, respectively).<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">These findings are important as the dosage of metformin needed to manage diabetes effectively often causes troubling gastrointestinal side effects. Metformin has long been considered the gold standard first line therapy to treat type 2 diabetes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A press release issued today by Depomed, Inc. and Santarus, Inc says that according to the clinical trial results, patients previously intolerant of metformin may be able to tolerate higher efficacious doses of metformin when treated with GLUMETZA, with fewer gastrointestinal side effects. GLUMETZA is a once-daily, extended release formulation of metformin, and is approved for use in adults with type 2 diabetes&#8230;<\/p>\n","protected":false},"author":131,"featured_media":29439,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1442],"tags":[843,261],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glumetza, Extended Release Metformin Shows Promise<\/title>\n<meta name=\"description\" content=\"according to the clinical trial results, diabetes patients previously intolerant of metformin may be able to tolerate higher doses when treated with GLUMETZA, with fewer side effects...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=8685\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=8685\",\"url\":\"https:\/\/asweetlife.org\/?p=8685\",\"name\":\"Glumetza, Extended Release Metformin Shows Promise\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=8685#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=8685#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png\",\"datePublished\":\"2010-06-28T14:17:23+00:00\",\"dateModified\":\"2015-12-29T14:01:19+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"according to the clinical trial results, diabetes patients previously intolerant of metformin may be able to tolerate higher doses when treated with GLUMETZA, with fewer side effects...\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=8685#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=8685\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=8685#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png\",\"width\":177,\"height\":59,\"caption\":\"depomed_logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=8685#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Type 2 Diabetics May be Able to Tolerate Higher Doses of Metformin Using Glumetza\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Glumetza, Extended Release Metformin Shows Promise","description":"according to the clinical trial results, diabetes patients previously intolerant of metformin may be able to tolerate higher doses when treated with GLUMETZA, with fewer side effects...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=8685","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=8685","url":"https:\/\/asweetlife.org\/?p=8685","name":"Glumetza, Extended Release Metformin Shows Promise","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=8685#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=8685#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png","datePublished":"2010-06-28T14:17:23+00:00","dateModified":"2015-12-29T14:01:19+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"according to the clinical trial results, diabetes patients previously intolerant of metformin may be able to tolerate higher doses when treated with GLUMETZA, with fewer side effects...","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=8685#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=8685"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=8685#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/06\/depomed_logo1-1.png","width":177,"height":59,"caption":"depomed_logo"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=8685#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Type 2 Diabetics May be Able to Tolerate Higher Doses of Metformin Using Glumetza"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/8685"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8685"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/8685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/29439"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}